[1]杨满英,陈雪珍,朱蓉,等.康艾注射液干预乳腺癌的网络药理学研究[J].中国中医药图书情报杂志,2022,46(1):6-13.[doi:10.3969/j.issn.2095-5707.2022.01.002]
 YANG Man-ying,CHEN Xue-zhen,ZHU Rong,et al.Network Pharmacological Study on the Intervention of Kang’ai Injection in Breast Cancer[J].Chinese Journal of Library and Information Science for Traditional Chinese Medicine,2022,46(1):6-13.[doi:10.3969/j.issn.2095-5707.2022.01.002]
点击复制

康艾注射液干预乳腺癌的网络药理学研究

参考文献/References:

[1] 黎鹏.康艾注射液药效物质基础研究[D].长春:吉林大学,2019.
[2] 郭依俐,刘庆.康艾注射液的化学成分研究[J].今日药学,2019, 29(1):6-10.
[3] 莫宗权,敬娜,陈哓俊,等.基于网络药理学分析康艾注射液抗肿瘤作用机制[J].中药材,2019,42(10):2385-2393.
[4] 曹建,魏润杰,邓茹芸,等.苦参碱及氧化苦参碱抑制肿瘤作用机制研究进展及展望[J].中草药,2019,50(3):753-760.
[5] WU J, CAI Y, LI M L, et al. Oxymatrine promotes S-phase arrest and inhibits cell proliferation of human breast cancer cells in vitro through mitochondria-mediated apoptosis[J]. Biological and Pharmaceutical Bulletin, 2017,40(8):1232-1239.
[6] LIN B R, LI D N, ZHANG L. Oxymatrine mediates Bax and Bcl-2 expression in human breast cancer MCF-7 cells[J]. Die Pharmazie, 2016,71(3):154-157.
[7] 刘歆春.多西他赛、卡培他滨联合康艾注射液治疗晚期乳腺癌的效果观察[J].临床合理用药杂志,2020,13(28):92-94.
[8] 谢瑞杰,莫李立,李俊明,等.乳腺癌术后化疗期间辅助药物应用314例分析[J].山西医药杂志,2020,49(4):385-387.
[9] 孙跃瑜.康艾注射液联合CTF方案在乳腺癌新辅助化疗中的疗效研究[J].新中医,2019,51(11):164-167.
[10] 田叶红,赵建新,邱晓伟,等.黄金昶治疗乳腺癌及其并发症的经验[J].中华中医药杂志,2020,35(8):3985-3987.
[11] 周梦楠,陈向阳,陈晓鹤,等.基于“优势成分预测-潜在靶点筛选”的“2R网络药理学”的中药复方有效组分研究方法的构建[J].中国中药杂志,2021,46(9):2363-2369.
[12] LIU Y F, NI A, KEYS A, et al. Network pharmacology for traditional Chinese medicine research: methodologies and applications[J]. Chinese Herbal Medicines, 2015,7(1):18-26.
[13] LI J, LU C, JIANG M, et al. Traditional Chinese medicine-based network pharmacology could lead to new multicompound drug discovery[J]. Evidence-Based Complementary and Alternative Medicine, 2012,2012(12):149762.
[14] 黄曦文,何刚,伍春莲.黄酮醇及其改良剂型抗乳腺癌研究进展[J].生命科学,2020,32(5):494-500.
[15] ZHU L, XUE L J. Kaempferol suppresses proliferation and induces cell cycle arrest, apoptosis, and DNA damage in breast cancer cells[J]. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, 2019,27(6): 629-634.
[16] Imran M, Salehi B, Sharifi-Rad J, et al. Kaempferol: a key emphasis to its anticancer potential[J]. Molecules, 2019, 24(12):2277.
[17] CAO L B, YANG Y X, YE Z Y, et al. Quercetin-3-methyl ether suppresses human breast cancer stem cell formation by inhibiting the Notch1 and PI3K/Akt signaling pathways[J]. International Journal of Molecular Medicine, 2018, 42(3): 1625-1636.
[18] Aghapour F, Moghadamnia A A, Nicolini A, et al. Quercetin conjugated with silica nanoparticles inhibits tumor growth in MCF-7 breast cancer cell lines[J]. Biochemical and Biophysical Research Communications, 2018,500(4):860-865.
[19] YI X F, ZUO J C, TAN C, et al. Kaempferol, a flavonoid compound from gynura medica induced apoptosis and growth inhibition in MCF-7 breast cancer cell[J]. African Journal of Traditional, Complementary and Alternative Medicines, 2016,13(4):210-215.
[20] HU G W, LIU H J, WANG M, et al. IQ motif containing GTPase-activating protein 3 (IQGAP3) inhibits kaempferol-induced apoptosis in breast cancer cells by extracellular signal-regulated kinases 1/2 (ERK1/2) signaling activation[J]. Medical Science Monitor, 2019,25:7666-7674.
[21] LI S S, YAN T, DENG R, et al. Low dose of kaempferol suppresses the migration and invasion of triple-negative breast cancer cells by downregulating the activities of RhoA and Rac1[J]. Oncotargets & Therapy, 2017(10):4809-4819.
[22] LEE G A, CHOI K C, HWANG K A. Kaempferol, a phytoestrogen, suppressed triclosan-induced epithelial-mesenchymal transition and metastatic-related behaviors of MCF-7 breast cancer cells[J]. Environmental Toxicology and Pharmacology, 2017,49:48-57.
[23] Balakrishnan S, Mukherjee S, Das S, et al. Gold nanoparticles-conjugated quercetin induces apoptosis via inhibition of EGFR/PI3K/Akt-mediated pathway in breast cancer cell lines (MCF-7 and MDA-MB-231)[J]. Cell Biochemistry and Function, 2017,35(4):217-231.
[24] Niazvand F, Orazizadeh M, Khorsandi L, et al. Effects of quercetin-loaded nanoparticles on MCF-7 human breast cancer cells[J]. Medicina, 2019,55(4):114.
[25] 郝艳梅,殷红梅,朱超莽,等.苦参碱通过抑制PI3K/AKT/mTOR通路促进非小细胞肺癌A549细胞的自噬和凋亡[J].南方医科大学学报, 2019,39(7):760-765.
[26] MA K, HUANG M Y, GUO Y X, et al. Matrine-induced autophagy counteracts cell apoptosis via the ERK signaling pathway in osteosarcoma cells[J]. Oncology letters, 2016,12(3):1854-1860.
[27] 邵建斌,杨梅兰.miR-198靶向MAPK1对人乳腺癌MCF-7细胞增殖和凋亡的调控作用[J].中国肿瘤生物治疗杂志,2018,25(12):1259-1263.
[28] LI B, ZHANG X, CHENG W. Emodin interferes with AKT1-mediated DNA damage and decreases resistance of breast cancer cells to Doxorubicin[J]. Frontiers in Oncology, 2021,10:588533.
[29] Schmid P, Abraham J, Chan S, et al. Capivasertib plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer: the PAKT trial[J]. Clin Oncol, 2020,38(5):423-433.
[30] SONG D D, HE H, Sinha I, et al. Blocking Fra-1 sensitizes triple-negative breast cancer to PARP inhibitor[J]. Cancer Letters, 2021,506:23-34.
[31] 胡玲,张福田,张晓谦,等.槲皮素衍生物抗癌活性研究新进展[J].精细化工中间体,2020,50(3):5-13.
[32] RONG G H, YI Z B, MA F, et al. DNA damage response as a prognostic indicator in metastatic breast cancer via mutational analysis[J]. Annals of Translational Medicine, 2021,9(3):220.
[33] 卢义钦.介绍一个生物化学新词:膜筏[J].科技术语研究,2003, 5(4):37-39.
[34] JIANG H F, LI H P. Prognostic values of tumoral MMP2 and MMP9 overexpression in breast cancer: a systematic review and meta-analysis[J]. BMC Cancer, 2021,21(1):149.
[35] 陆慧敏,孙文熙,霍晨星,等.基于MEKK1/SEK1/JNK1/AP-1通路探讨三七总皂苷对4T1乳腺癌荷瘤小鼠肿瘤模型的影响[J].中国实验方剂学杂志,2020,26(24):75-81.

相似文献/References:

[1]张益.医院图书馆面向乳腺癌患者实施阅读疗法初探[J].中国中医药图书情报杂志,2019,43(3):60.[doi:10.3969/j.issn.2095-5707.2019.03.015]
 ZHANG Yi.Preliminary Study on Reading Therapy for Breast Cancer Patients in Hospital Libraries[J].Chinese Journal of Library and Information Science for Traditional Chinese Medicine,2019,43(1):60.[doi:10.3969/j.issn.2095-5707.2019.03.015]
[2]刘江峰,龚梦婷,戚桂波,等.基于中国科学引文索引数据库的乳腺癌研究文献计量分析[J].中国中医药图书情报杂志,2019,43(5):15.[doi:10.3969/j.issn.2095-5707.2019.05.004]
 LIU Jiang-feng,GONG Meng-ting,QI Gui-bo,et al.Bibliometric Analysis of Research on Breast Cancer Based on Chinese Science Citation Index Database[J].Chinese Journal of Library and Information Science for Traditional Chinese Medicine,2019,43(1):15.[doi:10.3969/j.issn.2095-5707.2019.05.004]

备注/Memo

收稿日期:2021-05-20

基金项目:湖南省教育厅科学研究项目(20A373);湖南省中医药管理局资助项目(2017106);湖南省技术创新引导计划科普专项(2018ZK4043)
第一作者:杨满英,E-mail: ymy819797203@163.com
*通讯作者:胡金辉,E-mail: hujinhui173@163.com

更新日期/Last Update:

2022-01-05